Dave Amerson is President of the Interventional Urology business unit for Teleflex, Inc. He joined Teleflex in October 2017 through the acquisition of Neotract, Inc. At NeoTract, he served as President, Chief Executive Officer and as a member of its Board of Directors since July 2011. From 2006 to 2011, Dave was Global Vice President, General Manager for the Urology division of Coloplast, a publicly traded medical equipment company based in Denmark. From 1990 to 2006, he worked at Mentor, a publicly traded medical device company, and he was Global Vice President of Sales and Marketing for the Urology division at the time Mentor was acquired by Coloplast in 2006. Prior to Mentor, he worked at Osbon Medical Systems, a private urological medical device company, in a variety of management roles. Dave is a former board member of the Urology Society of America and the American Lithotripsy Society. He holds a MBA from Argosy University and a BA in Political Science from the University of West Georgia.